Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05602051

Mindfulness-based Virtual Reality Intervention

Conditions: Hematologic Neoplasms

Sex: All
Ages: 18 Years – 85 Years
Phase: NA
Enrollment: 110
Sponsor: Nanjing University of Traditional Chinese Medicine

Location: China

Summary

Through virtual reality technology and mindfulness therapy, we can intervene the patients with Hematologic Neoplasms during chemotherapy, hoping to improve their symptoms and self-efficacy.

Eligibility Criteria

Inclusion Criteria:Clinical diagnosis of Hematologic Neoplasms(leukemia, lymphoma or multiple myeloma) and receiving chemotherapyHospitalized for more than 4 weeksHave normal communication ability, clear consciousness, and willing to participate in this studyExclusion Criteria:People are cognitive dysfunction and audio-visual dysfunctionHave mental problems or have reported mental disorders

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05602051). StuddyBuddy aggregates publicly available trial information.